Woodside, Darren G.
Article History
First Online: 29 May 2019
Compliance with Ethical Standards
:
: Dr. Woodside has a patent pending, PCT/US18/29991—Targeting Nanoparticles, and he is a co-founder of and investor in 7Hills Pharma, LLC, a startup biotechnology company developing novel immunotherapies for cancer.
: The article reviews work previously published by the author that involved animals. There are no unpublished animal studies included in this article.